Mark I Rosenblatt, MD, PhD, MBA, MHA
G. Stephen Irwin Executive Dean, University of Illinois College of Medicine
Chief Executive Officer, University of Illinois Hospital & Clinics
Director, Corneal Regenerative Medicine Laboratory
UIC Distinguished Professor
Department of Ophthalmology and Visual Sciences
Related Sites:
About
Mark I. Rosenblatt, MD, PhD, MBA, MHA has been the Executive Dean of the University of Illinois College of Medicine since 2019 and was appointed as the G. Stephen Irwin Executive Dean in 2023. He has also served as Chief Executive Officer of the University of Illinois Hospital and Clinics since 2024, and previously as Interim CEO since 2023. Dr. Rosenblatt was appointed Distinguished Professor of Ophthalmology and Visual Sciences in 2023, and previously served as the Illinois Lions/Charles I. Young Chair and Professor of Ophthalmology since 2014.
Prior to becoming Executive Dean, Dr. Rosenblatt served as Head of the Department of Ophthalmology and Visual Sciences at the University of Illinois College of Medicine. In addition, he served as Director of the Medical Scientist Training Program from 2019 to 2022. Before joining the University of Illinois College of Medicine, Dr. Rosenblatt was a faculty member at Weill Cornell Medical College from 2008 to 2014, including serving a term as Vice Chair of the Department of Ophthalmology.
Dr. Rosenblatt is an internationally recognized clinician-scientist. As Director of the Corneal Regenerative Medicine Laboratory, he leads groups of scientists investigating the mechanism of corneal peripheral nerve regeneration following injury, and the use of nanoengineered biomaterials for use in stem cell delivery to the ocular surface. His work in regenerative medicine has been funded by the National Institutes of Health, the Department of Defense, Research to Prevent Blindness, the Falk Family Foundation, and the Tri-Institutional Stem Cell Initiative. Dr. Rosenblatt has published widely, including over 150 original manuscripts, review
articles, book chapters, and abstracts.
Dr. Rosenblatt is a graduate of the University of Miami Miller School of Medicine’s Honors Program in Medical Education and the Combined MD/PhD program, receiving his PhD in Biochemistry, Cell, and Molecular Biology. He also completed his MBA at New York University and his MHA at the University of Illinois Chicago School of Public Health. Dr. Rosenblatt completed his ophthalmology residency and combined clinical/research fellowship in corneal disease at the Massachusetts Eye and Ear Infirmary/Harvard Medical School. He is a member of the Alpha Omega Alpha and Omicron Delta Kappa honor societies.
Publication Aggregators
Notable Honors
2014, Achievement Award, American Academy of Ophthalmology
2009-2013, Career Development Award, Research to Prevent Blindness
2005, Resident/Research Fellow Award, AUPO/Research to Prevent Blindness
2003-2005, Joint Clinical Research Center Fellowship, Massachusetts Eye and Ear Infirmary and Schepens Eye Research Institute
Education
MD: University of Miami School of Medicine
PhD in Biochemistry, Cell, and Molecular Biology: University of Miami School of Medicine
Residency in Ophthalmology: Massachusetts Eye and Ear Infirmary, Harvard Medical School
Research Fellowship: Schepens Eye Research Institute, Harvard Medical School
Clinical Fellowship in Cornea and External Disease: Massachusetts Eye and Ear Infirmary
MBA: New York University Stern School of Business
MHA: University of Illinois Chicago